Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma × Dasatinib × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Burkitt Lymphoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Myeloid, Chronic-Phase 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Brain Neoplasms 1 Blast Crisis 1

Interventions

Cyclophosphamide 18 Rituximab 13 Biopsy 13 fludarabine 12 Specimen Handling 10 Prednisone 9 Magnetic Resonance Spectroscopy 9 Lenalidomide 7 venetoclax 6 pembrolizumab 5 obinutuzumab 5 Doxorubicin 5 Vincristine 4 Mycophenolic Acid 4 Bendamustine Hydrochloride 4 trametinib 3 glofitamab 3 fludarabine phosphate 3 copanlisib 3 Whole-Body Irradiation 3 Tacrolimus 3 Methotrexate 3 Etoposide 3 Cytarabine 3 zanubrutinib 2 tocilizumab 2 polatuzumab vedotin 2 palbociclib 2 ibrutinib 2 X-Rays 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡